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Summary.-The determination of hormone inducible proteins in endocrine tumours
may yield information about the presence of hormone dependent tumour cells. We
have estimated the high affinity oestradiol binding capacity in primary mammary
carcinomata of 57 postmenopausal patients. Glucose-6-phosphate dehydrogenase
and lactose synthetase are known from animal experiments to be hormone inducible.
Therefore, in biopsies of sufficient size the activity of glucose-6-phosphate dehydro-
genase (47 patients) and lactose synthetase (23 patients) was also studied. It was
found that biopsies with high binding capacity also showed high activities of glucose-
6-phosphate dehydrogenase and lactose synthetase A protein (galactosyl transferase).
No lactose synthetase B protein (a-lactalbumin) has been discovered in the tumours.
The present observations may be considered suggestive evidence of a relationship
between high oestradiol binding capacity and high activities of the two enzymes on
the one hand and hormone dependence of the tumour on the other. However, further
clinical studies are required before final conclusions in this respect can be drawn.
THE SPECIFIC problem of developing
predictive tests for hormone dependence
in human mammary tumours is of con-
siderable importance in the planning of
rational endocrine therapy ofthis category
ofpatients. Determination of the content
of oestradiol receptors in the tumour has
proved to be valuable in predicting the
outcomeofendocrine ablationin mammary
cancer patients (Jensen et al., 1973), and
there are indications that there is a corre-
lation between the response to oestrogen
or anti-oestrogen therapy and the content
of receptor protein in the tumour (Engels-
man et al., 1973). Estimates of the
amounts of various proteins known to be
subject to hormonal regulation are con-
ceivably also of value in predicting the
hormone dependence of a given tumour.
From animal experiments, such pro-
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teins are known to include the hormone
inducible enzymes, glucose-6-phosphate
dehydrogenase (G-6-PDH) (Bonsignore
and De Flora, 1972) and lactose synthetase
(LS) (Turkington et al., 1968; Palmiter,
1969).
Investigations of this type have been
conducted in this laboratory using GR
mouse mammary tumours (Briand and
Daehnfeldt, 1973; Schulein, Daehnfeldt
and Briand, 1974). In these studies, we
have reported a higher G-6-PDH activity
in hormone dependent GR mouse mam-
mary tumours compared with independent
tumours. The LS A-protein activity in
the same tumour system was found to be
high in both dependent and independent
tumours, while LS B-protein was non-
detectable in tumour tissue.
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attempt to put the knowledge and
experience that we have gained experi-
menting with the animal model to work
in human mammary tumours. The in-
vestigation includes a study of the activity
of G-6-PDH and LS A-protein and the
content of LS B-protein and high affinity
oestradiol receptor protein in mammary
carcinomata of postmenopausal women.
However, clinical validation of such bio-
chemical predictions can be obtained only
through prospective therapeutic trials.
MIATERIALS AND METHODS
Tumour specimens were obtained from
patients in whom menostasis had persisted
for at least 6 months, wzThich wxas used as the
criterion of their being in a postmenopausal
state. Histological diagnoses from these
patients ere obtained from the hospital files.
Tumour tissue as placed on carbon
dioxide ice immediately after excision, trans-
ported to the laboratory and either stored
at -80°C or further processed. The tissue
wN-as homogenized in a micro-dismembrator
(Braun, Melsungen, West Germany) after
cooling in liquid nitrogen. The resulting
powder was weighed and distributed for
dilution with appropriate buffers. The
powder was carefully mixed with the buffers
and particle-free supernatants were prepared
by centrifugation at 100,000 g for one h at
4°C. The supernatants were either imme-
diately assayed or stored at -80°C. The
oestrogen receptor protein and enzyme
activities w\ere found to be stable for up to
3-4 weeks under these conditions.
A modification (Daehnfeldt, 1974) of the
charcoal adsorption method described by
Mester et al. (1970) w%as used to assay the
high affinity oestradiol receptor protein. The
method used w%Aas nearly identical with the
nethod recommended by the EORTC Breast
Cancer Cooperative Group (1973) and only
non-blocked receptor sites Mwere estimated.
Results w-ere expressed as mol oestradiol
bound/mg supernatant protein. KD for the
hormone receptor complex was calculated
from the slope of the Scatchard plots.
The protein concentration was not cor-
rected for contamination by serum proteins;
a preliminary assay of serum albumin by
rocket immunoelectrophoresis a.mn. Laurell
(1966) showed that this contamination varied
from 10 to 20%. The first 20 tumour speci-
mens were also tested for oestradiol binding
capacity using the agar gel electrophoresis
method (Wagner, 1972). Only 2 of the 20
specimens tested differed significantly in
oestradiol binding capacity from the results
obtained using the charcoal technique. Thus,
unspecific binding did not seem to be a greater
source of error in the charcoal technique.
The activity of G-6-PDH was determined
spectrophotometrically according to the prin-
ciple ofGlock and McLean (1953) as described
by Briand and Daehnfeldt (1973) by moni-
toring the formation of NADPH at 340 nm
in an assay volume of 1-0 ml. Results were
expressed as ng/mg supernatant protein. A
modification (Schiilein et al., 1974) of the
radiochemical method ofBrew, Vanaman and
Hill (1968) wfas applied to determine LS
activity. UDP-14C-galactose was used as
labelled precursor. Onlysoluble LS A-protein
was routinely determined but fractionated
determinations were performed using Triton-
X-100 to solubilize particle bound LS A-
protein. With the preparationtechniqueused
in this study, more than 90%o of the LS
A-protein activity was recovered in the
soluble fraction. LS B-protein was deter-
mined with an excess of bovine LS A-protein,
prepared from cow's milk whey.
The distribution of the data obtained was
not normal. Therefore, statistical evaluation
was performed with the nonparametric
Wilcoxon's rank test (Ciba-Geigy Scientific
Tables, 1970).
RESULTS
Determinations of the high affinity
oestradiol receptor protein fall into the
following two groups: Group I, in which
less than 2 X 10-14 mol oestradiol is
bound/mg protein (this corresponds to
twice the detection limit), and Group II,
in which more than 2 x 10-14 mol oestra-
diol is bound/mg protein.
From the Table it appears that 31 of
57 cases can be considered to be receptor
positive (Group II), while 26 cases are
negative. Out ofthe 31 patients in Group
II, 18 show an oestradiol binding capacity
larger than 10 x 10-14 mol/mg protein.
The median KD value in this subgroup is
2 x 10-9 mol.
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TABLE. Aye Distribution, Non-blocked Oestradiol Bindiny (Capacity, Glucose-6-phosphate
Dehydroqenase and Lactase Synthetase Activity in Mamnmary C(arcinomata of
Postmenopausal Women
Age distributioin (years)
Oestradiol binding capacity (mol
oestradiol/mg protein x 1014)
G-6-PDH (ng/mg protein)
Lactose synthetase A-protein (pmol
lactose/mg protein/min)
Lactose synthetase B-protein (yog cow
B-protein/mg protein)
n = No. of patients.
* I compared with IL: P 0= 02.




















7-1 0:3-65-2 23 14-7 1-7-29-6 24*
85 33-280 9 234 77 450 l4t
<2-()
The median value ofG-6-PDH activity
in Group II is significantly higher (P_
0.02) than in Group I. The activity of LS
A-protein is also significantly higher in
Group II than in Group I (P < 0 01). No
LS B-protein has been found in the human
tumour supernatants using an assay that
is able to detect amounts equivalent to
2 Itg cow B-protein/mg protein.
DISCUSSION
In the present study, the tumours of
approximately 50% of the cases investi-
gated (Group II) were found to be
receptor positive. This finding agrees
with both the findings of Wittliff et al.
(1972) and Leclerq et al. (1973). The
binding capacities showed considerable
variations which for some cases can
probably be explained by differences in
the oestradiol concentrations in the serum
of the individual patients. A maximum
concentration of oestradiol of about 2 x
10-1 mol has been found in normal
postmenopausal women. This value is
about 40 times lower than the value in
normal premenopausal women (England
et al., 1974).
Taking the KD value of 2 x 10-9 mol
into consideration, the experimentally
determined binding capacity for oestradiol
in the subgroup, showing binding capa-
cities larger than 10 x 10-14 mol/mg p.o-
tein, may be expected to be a good
- 9 <2 () - 6
approximation of the number of total
receptor sites in postmenopausal patients.
However, if any of the patients have
an oestradiol concentration which ap-
proaches the normal premenopausal con-
centration, the experimentally determined
binding capacity for oestradiol will reflect
an incorrect, low content of receptor
protein (Daehnfeldt, 1974). We believe
that this may have been the case in the
patients with binding capacities between
2 and 10 x 10-14 mol of oestradiol bound/
mg protein.
In agreement with both Wittliff et al.
(1972) and Leclerq et al. (1973) we have
found no correlation between the histo-
logical classification of the tumour and
the receptor content.
Jensen's (1973) histochemical investi-
gation of the G-6-PDH showed a high
enzyme activity ill 480% of the human
mammary carcinomata investigated. This
is in agreement with our findings.
The concordance between the high
binding capacity observed in the present
study and high G-6-PDH activity in the
human mammary tumours is in agreement
with our previous findings in GR mouse
mammary tumours. The development
ofhormone independence ofthese tumours
is accompanied by decreased G-6-PDH
activity (Briand and Daehnfeldt, 1973)
and oestradiol receptor content (Terenius,
1972; Daehnfeldt, unpublished). On the
other hand, according to Hilf et al. (1973)
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the oestradiol binding capacity in human
mammary carcinomata seems to be un-
related to the activity of G-6-PDH. The
material used in Hilf's study included
premenopausal patients and, for reasons
mentioned above, determinations of the
binding capacity oftumours from pre- and
postmenopausal patients are not directly
comparable.
LS B-protein was not detectable in
human mammary tumours. This is in
agreement with our previous investiga-
tions of murine mammary tumours
(Schuilein et al., 1974). However, the
difference in LS A-protein activity in
human tumours with high and low
receptor content is not completely in
agreement with our previous findings in
GR mice. In GR mouse LS A-protein
activity is high in both hormone dependent
and independent tumours in spite of
(lifferences in receptor content (Schiulein
et al., 1974). As already mentioned,
animal experiments have shown G-6-PDH
and LS to be hormone inducible. Whether
this is also the case in women is not
known. However, if this is so the high
activities of G-6-PDH and LS-A found in
the present study in tumours with high
contents of oestradiol receptor protein
indicate that the receptor protein in these
tumours is functional at the oestrogen
concentration present in the patients.
The reports by Jensen et al. (1973) and
Engelsman et al. (1973) referred to above,
suggest a correlation between the content
ofoestradiol receptor protein and hormone
dependence in human mammary tumours.
A similar correlation with G-6-PDH and
LS-A activities might possiblybeexpected.
In order to clarify this possibility, we have
started a controlled clinical study of the
correlation between the biochemical para-
meters discussed in the present com-
munication and the response of primary
humani mammary cancer to oestrogen and
anti-oestrogen treatment.
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